MetLife Investment Management’s Aehr Test Systems AEHR Stock Holding History

MetLife Investment Management’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$614K	Sell	16,549 -153	-0.9%	-$4.89K	﹤0.01%	1654
2025 Q4	$337K	Hold	16,702	–	–	﹤0.01%	1988
2025 Q3	$503K	Sell	16,702 -2,066	-11%	-$44.7K	﹤0.01%	1799
2025 Q2	$243K	Buy	18,768 +3,624	+24%	+$34.5K	﹤0.01%	2086
2025 Q1	$110K	Hold	15,144	–	–	﹤0.01%	2482
2024 Q4	$252K	Hold	15,144	–	–	﹤0.01%	2182
2024 Q3	$195K	Hold	15,144	–	–	﹤0.01%	2301
2024 Q2	$169K	Buy	15,144 +1,491	+11%	+$17.4K	﹤0.01%	2349
2024 Q1	$169K	Hold	13,653	–	–	﹤0.01%	2286
2023 Q4	$362K	Hold	13,653	–	–	﹤0.01%	1879
2023 Q3	$624K	Hold	13,653	–	–	﹤0.01%	1487
2023 Q2	$563K	Buy	+13,653	New	+$448K	﹤0.01%	1621

Other funds holding AEHR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MetLife Investment Management's AEHR Position: Q1 2026 in Review

MetLife Investment Management reduced its Aehr Test Systems (AEHR) stake by 0.92% in Q1 2026, selling an estimated $4.89K and leaving 16,549 shares worth $614K. The position accounts for ﹤0.01% of the portfolio, ranked #1654.

MetLife Investment Management first reported a position in AEHR in Q2 2023 and has held it in 12 quarters since. The position peaked at $624K in Q3 2023. 191 funds tracked by Wall St. Rank hold AEHR as of Q1 2026.

MetLife Investment Management held 16,549 shares of Aehr Test Systems worth $614K as of Q1 2026.
MetLife Investment Management sold 153 Aehr Test Systems shares in Q1 2026, an estimated $4.89K.
Aehr Test Systems made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1654 holding.
MetLife Investment Management first reported a position in Aehr Test Systems in Q2 2023 and has held it in 12 quarters since.
MetLife Investment Management's Aehr Test Systems position peaked at $624K in Q3 2023.
191 funds tracked by Wall St. Rank held Aehr Test Systems as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.